





























Link to publication record in King's Research Portal
Citation for published version (APA):
Coleman, J. R. I., Peyrot, W. J., Purves, K., Davis, K. A. S., Rayner, C., Choi, S. W., Huebel, C., Gaspar, H. A.,
Kan, C., der Auwera, S. V., Adams, M. J., Lyall, D., Choi, K. W., Major Depressive Disorder Working Group of
the Psychiatric Genomics Consortium, Dunn, E. C., Vassos, E., Danese, A., Maughan, B., Grabe, H. J., ...
Howard, D. (2020). Genome-wide gene-environment analyses of major depressive disorder and reported lifetime
traumatic experiences in UK Biobank. Molecular Psychiatry, 25(7), 1430-1446. https://doi.org/10.1038/s41380-
019-0546-6
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 23. Jan. 2021
0 
 
Genome-wide gene-environment analyses of major depressive disorder and 
reported lifetime traumatic experiences in UK Biobank 
Jonathan R.I. Coleman1,2, Wouter J. Peyrot3, Kirstin L. Purves1, Katrina A.S. Davis2,4, 
Christopher Rayner1, Shing Wan Choi1, Christopher Hübel1,2, Héléna A. Gaspar1,2, 
Carol Kan4, Sandra Van der Auwera5, Mark James Adams6, Donald M. Lyall7, 
Karmel W. Choi8,9,10,11, Major Depressive Disorder Working Group of the Psychiatric 
Genomics Consortium12, Erin C. Dunn10,11,13, Evangelos Vassos1,2, Andrea 
Danese1,14,15, Barbara Maughan1, Hans J. Grabe5, Cathryn M. Lewis1,2, Paul F. 
O'Reilly1, Andrew M. McIntosh6, Daniel J. Smith7, Naomi R. Wray16,17, Matthew 
Hotopf2,4, Thalia C. Eley1,2*, Gerome Breen1,2* 
1 Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, 
Psychology & Neuroscience, King’s College London, London, UK 
2 NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS 
Trust, London, UK 
3 Amsterdam UMC, Vrije Universiteit Medical Center, Department of Psychiatry, 
Amsterdam, The Netherlands 
4 Department of Psychological Medicine, Institute of Psychiatry, Psychology & 
Neuroscience, King’s College London, London, UK 
5 Department of Psychiatry and Psychotherapy, University Medicine Greifswald, 
Greifswald, Germany 
6 Division of Psychiatry, University of Edinburgh, Edinburgh, UK 
7 Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK 
8 Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA 
9 Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, 
MA, USA 
10 Stanley Center for Psychiatric Research, The Broad Institute of Harvard and MIT, 
Cambridge, MA, USA 
11 Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, 
Massachusetts General Hospital, Boston, MA, USA 
12 Consortium members listed in Supplementary Materials 
13 Department of Psychiatry, Harvard Medical School, Boston, MA, USA 
1 
14 Department of Child and Adolescent Psychiatry, Institute of Psychiatry, 
Psychology & Neuroscience, King’s College London, London, UK 
15 National and Specialist CAMHS Trauma and Anxiety Clinic, South London and 
Maudsley NHS Foundation Trust, London, UK 
16 Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 
Australia 
17 Queensland Brain Institute, The University of Queensland, Brisbane, QLD, 
Australia 
 
* Address correspondence to Dr Gerome Breen (gerome.breen@kcl.ac.uk, 
+442078480409) or Prof. Thalia Eley (thalia.eley@kcl.ac.uk, +442078480863), 
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, 




Depression is more frequent among individuals exposed to traumatic events. Both 2 
trauma exposure and depression are heritable. However, the relationship between 3 
these traits, including the role of genetic risk factors, is complex and poorly 4 
understood. When modelling trauma exposure as an environmental influence on 5 
depression, both gene-environment correlations and gene-environment interactions 6 
have been observed. The UK Biobank concurrently assessed Major Depressive 7 
Disorder (MDD) and self-reported lifetime exposure to traumatic events in 126,522 8 
genotyped individuals of European ancestry. We contrasted genetic influences on 9 
MDD stratified by reported trauma exposure (final sample size range: 24,094-10 
92,957). The SNP-based heritability of MDD with reported trauma exposure (24%) 11 
was greater than MDD without reported trauma exposure (12%). Simulations 12 
showed that this is not confounded by the strong, positive genetic correlation 13 
observed between MDD and reported trauma exposure. We also observed that the 14 
genetic correlation between MDD and waist circumference was only significant in 15 
individuals reporting trauma exposure (rg = 0.24, p = 1.8x10-7 versus rg = -0.05, p = 16 
0.39 in individuals not reporting trauma exposure, difference p = 2.3x10-4). Our 17 
results suggest that the genetic contribution to MDD is greater when reported trauma 18 
is present, and that a complex relationship exists between reported trauma 19 
exposure, body composition, and MDD. 20 
  21 
3 
Introduction 1 
Depression is among the most common mental illnesses worldwide and 2 
accounts for 5.5% of all years lost through disability globally 1. In England 3 
approximately 28% of individuals self-report depression during their lifetime 2. The 4 
most common clinically recognised form of depression is called Major Depressive 5 
Disorder (MDD). Both environmental and genetic factors influence MDD. In 6 
particular, MDD is more commonly observed among individuals reporting exposure 7 
to stressful life events and early-life traumas 3–6. In turn, reported trauma exposure 8 
has been robustly correlated with a range of adverse life outcomes including MDD 6–9 
9. The relationship between MDD and reported trauma exposure is complex. 10 
Reported trauma exposure is associated with both subsequent MDD and prior MDD 11 
10,11. However, the majority of people reporting exposure to traumatic experiences do 12 
not report MDD 6–9. 13 
Twin studies show that MDD is moderately heritable, with 30-40% of the 14 
variance in MDD attributable to genetic factors 12. The proportion of heritability 15 
captured by common genetic variants, also known as single nucleotide 16 
polymorphism or SNP-based heritability, can be estimated from genome-wide 17 
association study (GWAS) data. Such estimates tend to be lower than those 18 
obtained from twin approaches, due to the incomplete capture of genetic information 19 
in GWAS data among other reasons 13. The most recent major depression GWAS 20 
from the Psychiatric Genomics Consortium was anchored in 35 cohorts (including 21 
the 23andMe discovery cohort 14) recruited with a variety of methods 15. This meta-22 
analysis identified 44 loci significantly associated with major depression, and 23 
estimated a SNP-based heritability of 9-10% 15. These results strongly suggest both 24 
4 
the mild and more severe forms of depression are polygenic, with potentially 1 
thousands of variants with very small individual effects contributing to risk. 2 
There are far fewer genetic studies of reported trauma exposure than of MDD. 3 
However, the available studies have demonstrated that reported trauma exposure is 4 
heritable, with twin heritability estimates of 20-50% 16–18 and SNP-based heritability 5 
estimates of 30% 19. Combining measures of trauma exposure and depression at 6 
scale is difficult, given the need for careful phenotyping 20. Potential confounds 7 
include the (often unavoidable) use of retrospective self-reported measures of 8 
trauma exposure, which can be weakly correlated with objective measures of 9 
traumatic experiences 9. Furthermore, current (i.e. state) low mood can increase self-10 
reporting of previous trauma exposure 9,21. Previous individual study cohorts have 11 
generally been too small for effective GWAS, while meta-analyses have contained 12 
considerable heterogeneity due to the use of different phenotyping instruments in the 13 
included studies. 14 
However, some notable genome-wide analyses of MDD and trauma exposure 15 
have been performed. A genome-wide by environment interaction study of 16 
depressive symptoms and stressful life events in 7,179 African American women 17 
identified a genome-wide association near the CEP350 gene (although this did not 18 
replicate in a smaller cohort) 22. An investigation in 9,599 Han Chinese women with 19 
severe MDD identified three variants associated with MDD in individuals who did not 20 
report trauma exposure prior to MDD onset 23.  21 
Several attempts have been made to estimate the interaction of overall 22 
genetic risk and trauma by using polygenic risk scores for MDD to perform polygenic 23 
risk score-by-trauma interaction analyses. Such studies test whether there are 24 
departures from additivity (where the combined effect of risk score and trauma differs 25 
5 
from the sum of the individual effects) or from multiplicativity (where the combined 1 
effect differs from the product of the individual effects). Reported results have been 2 
highly variable, with findings of both significant additive and multiplicative interactions 3 
24; significant multiplicative interactions only 25; and, in the largest previous study 4 
published (a meta-analysis of 5,765 individuals), no interactions 26. 5 
Studies of gene-environment interaction usually assume the genetic and 6 
environmental influences are independent and uncorrelated 27. However, genetic 7 
correlations between reported trauma exposure and MDD have been reported, both 8 
from twin studies 28–30 and from the genomic literature 22,26. Reports of the magnitude 9 
of this genetic correlation have varied widely, which reflects differences in defining 10 
trauma exposure, and in the populations studied. While some studies have identified 11 
a very high genetic correlation (95%) 22, others have found no such correlation 23. 12 
The genetic relationship between reported trauma exposure and MDD is therefore 13 
unresolved. 14 
The release of mental health questionnaire data from the UK Biobank 15 
resource provides an opportunity to assess the relationship between genetic 16 
variation, risk for MDD, and reported trauma exposure in a single large cohort. We 17 
performed GWAS of MDD (as defined from the mental health questionnaire 31) with 18 
and without reported lifetime trauma exposure in UK Biobank European ancestry 19 
individuals. These results enabled us to estimate the genetic contribution (via SNP-20 
based heritability estimation) to MDD in individuals with and without reported lifetime 21 
trauma exposure. To examine differences in the genetic contribution, we calculated 22 
the genetic correlation between MDD in individuals reporting and not reporting 23 
trauma exposure. To assess whether the genetic relationship of MDD to other traits 24 
varies in the context of reported trauma exposure, we assessed genetic correlations 25 
6 
with a wide range of physical and psychiatric traits. Finally, we performed polygenic 1 
risk scoring, using external traits commonly comorbid with MDD, and sought to 2 
extend previous analyses of PRS-by-trauma interactions in MDD. 3 
 4 
Methods  5 
Phenotype definitions 6 
The UK Biobank assessed a range of health-related phenotypes and 7 
biological measures including genome-wide genotype data in approximately 500,000 8 
British individuals aged between 40 and 70 32. This includes 157,366 participants 9 
who completed an online follow-up questionnaire assessing common mental health 10 
disorders, including MDD symptoms, and 16 items assessing traumatic events 11 
(Resource 22 on http://biobank.ctsu.ox.ac.uk) 31. Phenotypes were derived from this 12 
questionnaire, using definitions from a recent publication describing its phenotypic 13 
structure 31.  14 
Individuals with probable MDD met lifetime criteria based on their responses 15 
to questions derived from the Composite International Diagnostic Interview (CIDI; 16 
Supplementary Table 1). We excluded cases if they self-reported diagnoses of 17 
schizophrenia, other psychoses, or bipolar disorder. Controls were excluded if they 18 
self-reported any mental illness, taking any drug with an antidepressant indication, or 19 
had been hospitalised with a mood disorder or met previously-defined criteria for a 20 
mood disorder (Supplementary Table 1) 33.  21 
Participants were asked questions relating to traumatic experiences in 22 
childhood using the Childhood Trauma Screener (a shortened version of the 23 
Childhood Trauma Questionnaire 34–36) and an equivalent screener for adulthood 24 
developed by the UK Biobank Mental Health steering group to mirror the childhood 25 
7 
items 31. In addition, participants were asked questions related to events that 1 
commonly trigger post-traumatic stress-disorder (PTSD). Responses to individual 2 
questions (items) in these three categories (child trauma, adult trauma, PTSD-3 
relevant trauma) were dichotomised and compared between MDD cases and 4 
controls (Supplementary Table 2a).  5 
We selected reported items with an odds ratio > 2.5 with MDD, to obtain a 6 
single binary variable for stratification that captured exposure to the traumatic events 7 
most associated with MDD. Items from all three trauma categories were reported 8 
more in MDD cases compared to controls. Of the selected items, three referred to 9 
events in childhood (did not feel loved, felt hated by a family member, sexually 10 
abused). Another three items referred to events in adulthood (physical violence, 11 
belittlement, sexual interference), and one item assessed a PTSD-relevant event 12 
(ever a victim of sexual assault). In order to capture increased severity of exposure, 13 
only individuals reporting two or more of these items were included as reporting 14 
trauma exposure. Individuals reporting none of the items were included as not 15 
reporting trauma exposure. Individuals reporting a single trauma item, or who did not 16 
provide an answer were excluded from the analyses (Supplementary Table 1). A 17 
breakdown of reported traumatic experiences by sex and MDD status is provided in 18 
Supplementary Table 2b. Further discussion of the definition of trauma exposure is 19 
included in the Supplementary Note. 20 
 21 
Phenotype preparation for analyses 22 
Three sets of analyses comparing MDD cases and controls were performed 23 
(i) overall, (ii) limited to individuals reporting trauma exposure, and (iii) limited to 24 
individuals not reporting trauma exposure (Table 1). In addition, sensitivity analyses 25 
8 
were performed on reported trauma exposure (overall and stratified by MDD 1 
diagnosis; see Supplementary Methods and Results, and Supplementary Table 3). 2 
For each analysis, phenotypes were first residualised on 6 ancestry principal 3 
components from the genetic data of the European samples as well as factors 4 
capturing initial assessment centre and genotyping batch. More details on phenotype 5 
preparation can be found in the Supplementary Methods.  6 
 7 
Phenotype distribution 8 
Previous analyses have shown that, compared to the participants in the UK 9 
Biobank as a whole, those who completed the mental health questionnaire were 10 
more likely to have a university degree, came from a higher socioeconomic 11 
background, and reported fewer long-standing illnesses or disabilities 31. 12 
Accordingly, participants were compared across a number of standard demographic 13 
variables and common correlates of MDD: sex, age (at questionnaire), education 14 
(university degree vs. not), neighbourhood socioeconomic status (SES, as 15 
Townsend deprivation index 37) and BMI (recorded from measurements taken at the 16 
initial recruitment of the participants into the biobank). For further details on these 17 
analyses, see Supplementary Methods. 18 
 19 
Genetic data 20 
Genetic data for GWAS analyses came from the full release of the UK 21 
Biobank data (N=487,410; 38). Autosomal genotype data from two highly-overlapping 22 
custom genotyping arrays (covering ~800,000 markers) underwent centralised 23 
quality control before being imputed in a two-stage imputation to the Haplotype 24 
Reference Consortium (HRC) and UK10K (for rarer variants not present in the HRC) 25 
9 
reference panels 38–40. In addition to this central quality control, variants for analysis 1 
were limited to common variants (minor allele frequency > 0.01) that were either 2 
directly genotyped or imputed from the HRC with high confidence (IMPUTE INFO 3 
metric > 0.4) 39. 4 
Individuals were excluded where recommended by the UK Biobank core 5 
analysis team for unusual levels of missingness or heterozygosity, or if they had 6 
withdrawn consent for analysis. Using the genotyped SNPs, individuals with call rate 7 
< 98%, who were related to another individual in the dataset (KING r < 0.044, 8 
equivalent to removing up third-degree relatives and closer 41) or whose phenotypic 9 
and genotypic gender information was discordant (X-chromosome homozygosity (FX) 10 
< 0.9 for phenotypic males, FX > 0.5 for phenotypic females) were also excluded. 11 
Removal of relatives was performed using a "greedy" algorithm, which minimises 12 
exclusions (for example, by excluding the child in a mother-father-child trio). All 13 
analyses were limited to individuals of European ancestry, as defined by 4-means 14 
clustering on the first two genetic principal components provided by the UK Biobank 15 
42. This ancestry group included 95% of the respondents to the mental health 16 
questionnaire - as such, the non-European ancestry groups were considered too 17 
small to analyse informatively. Principal components analysis was also performed on 18 
the European-only subset of the data using the software flashpca2 43. After quality 19 
control, individuals with high-quality genotype data and who had completed the 20 
online mental health questionnaire were retained for analysis (N=126,522). 21 
GWAS analyses used the imputed data as described above. Genetic 22 
correlation analyses used the results of the GWAS analyses. Polygenic risk score 23 
analyses and SNP-based heritability analyses in BOLT-LMM used the genotyped 24 
variants 38. These latter analyses were limited to common variants (minor allele 25 
10 
frequency > 0.01) with call rate >98% that were in approximate Hardy-Weinberg 1 
equilibrium (HWE test p > 10-8). The same individuals were used for analyses using 2 
the imputed and the genotyped data. 3 
 4 
Analyses 5 
Genome Wide Association Studies (GWAS) 6 
GWAS were performed to assess the association of individual genetic 7 
variants with MDD. These analyses were first undertaken for the entire sample 8 
regardless of reported trauma exposure, then stratified by reported trauma exposure. 9 
GWAS were performed using linear regressions on imputed genotype dosages in 10 
BGenie v1.2 38, with residualised phenotypes as described above. Phenotypes and 11 
genotypes were mean-centred and standardised. Genome-wide significance was 12 
defined at the conventional level p < 5 x 10-8 44. Results from each GWAS were 13 
clumped to define genetic loci in PLINK2 45. Loci were defined following established 14 
protocols (Supplementary Methods) 15. 15 
Betas from the GWAS were converted to odds ratios (OR) using LMOR 16 
(http://cnsgenomics.com/shiny/LMOR/) and observed sample prevalences 46. 17 
Standard errors were calculated from the p-value and estimated OR 47. Performing 18 
GWAS on residuals, rather than including covariates in the analysis, is a restriction 19 
imposed by the BGenie software (which was used because it is specifically designed 20 
for analysing the UK Biobank genetic data). Sensitivity analyses were performed to 21 
test for biases resulting from this method. Specifically, for each GWAS, each variant 22 
with nominal significance (p<0.0001) was also tested using logistic regression 23 
including covariates in R 3.4.1, in order to confirm the results from BGenie 48.  24 
 25 
11 
SNP-based heritability  1 
Results from GWAS were combined to assess the proportion of variance due 2 
to the additive effect of common genetic variants (SNP-based heritability). SNP-3 
based heritability was calculated on the observed scale using BOLT-LMM v2.3 49. 4 
The estimate for MDD in the cohort was converted to the liability scale in R 3.4.1, 5 
assuming a population prevalence of 28% 2,50. Converting estimates of SNP-based 6 
heritability for a case-control trait from the observed scale to the liability scale 7 
requires accurate estimates of the lifetime prevalence of the trait in the 8 
(sub)population. When comparing a trait stratified by a correlated variable (as is the 9 
case when we compare the SNP-based heritability of MDD stratified by reported 10 
trauma exposure), the population prevalence in each stratum is unknown. To 11 
address this, we approximated the expected prevalence of MDD in individuals either 12 
reporting or not reporting trauma exposure (Supplementary Methods). This allowed 13 
us to convert the observed scale SNP-based heritability of MDD to the liability scale 14 
in both strata (i.e. those reporting and those not reporting trauma exposure). A 15 
second challenge is that trauma exposure is itself a heritable trait that is genetically 16 
correlated with MDD in this study. The potential impact of this on SNP-based 17 
heritability estimation is not intuitive. To benchmark our findings, we performed 18 
simulations of SNP-level data to explore the expected SNP-based heritability of MDD 19 
in individuals reporting and not reporting trauma exposure, assuming differences in 20 
SNP-based heritability resulted only from the genetic correlation between MDD and 21 
reported trauma exposure. Further details of these analyses are provided in the 22 
Supplementary Methods. 23 
 24 
  25 
12 
Genetic correlations 1 
Genetic correlations (rg) were calculated to assess shared genetic influences 2 
between MDD and other phenotypes, using GWAS summary statistics and LD Score 3 
regression v1.0.0 51 using the default HapMap LD reference. Two sets of genetic 4 
correlations were calculated. First, we calculated genetic correlations between the 5 
phenotypes examined within this paper (internal phenotypes). We calculated the 6 
genetic correlation between MDD and reported trauma exposure in the full dataset, 7 
and then the genetic correlation between MDD in individuals reporting trauma 8 
exposure and MDD in individuals not reporting trauma exposure. Secondly, we also 9 
calculated genetic correlations between each GWAS from this analysis and a 10 
curated list of 308 publicly-available phenotypes (external phenotypes) 51,52. 11 
Genetic correlations were tested for difference from 0 (default in LD Score), 12 
and for difference from 1 (in Microsoft Excel, converting rg to a chi-square as [(rg-13 
1)/se]2) 51,52. Genetic correlations were considered significant if they passed the 14 
Bonferroni-adjusted threshold for the effective number of traits studied in each 15 
analysis (internal: p < 0.01; external: p < 2.5x10-4). The effective number of traits was 16 
calculated as the number of principal components explaining 99.5% of the variance 17 
in the pairwise genetic correlation matrix (internal: 5; external: 202). External 18 
phenotype GWAS all had heritability estimates such that h2/SE > 2, and produced 19 
valid (i.e. non-NA) rg with all other phenotypes tested. 20 
The genetic correlation of MDD with each external phenotype was compared 21 
between individuals reporting trauma exposure and individuals not reporting trauma 22 
exposure using a two-stage method. First, differences were assessed using two 23 
sample z-tests 53. Nominally-significant differences (p < 0.05) by this method were 24 
then compared using the block-jackknife (Supplementary Methods) 52,54,55. Results 25 
13 
using the jackknife were considered significant if they passed the Bonferroni-1 
adjusted threshold (p < 2.5x10-4). 2 
 3 
Polygenic Risk Scoring 4 
Polygenic risk scores were calculated to further assess shared genetic influences 5 
between MDD and traits known to be correlated to MDD. Specifically, risk scores 6 
from analyses of major depression (MDD) 15, schizophrenia (SCZ) 56, bipolar 7 
disorder (BIP) 57, body mass index (BMI) 58 and glycated haemoglobin (HbA1c; used 8 
as a negative control) 59 were calculated and compared in all participants and 9 
stratifying by reported trauma exposure. The PGC major depression GWAS 10 
contained participants from UK Biobank, so to derive the MDD risk score we used a 11 
restricted set of summary statistics without these individuals (but including 12 
individuals from 23andMe, whose diagnoses were self-reported 14). For further 13 
discussion of this overlap, see Supplementary Note 15. Risk scores were calculated 14 
using PRSice v2 at seven thresholds (external GWAS p < 0.001, 0.05, 0.1, 0.2, 0.3, 15 
0.4 and 0.5) to allow assessment of the spread of association between risk score 16 
and MDD 45,60,61. Analyses used logistic regression, including all covariates used in 17 
creating the residuals for GWAS. In total, five external phenotypes were used to 18 
produce risk scores for the three target phenotypes (MDD overall, and stratified by 19 
reported trauma exposure/non-exposure), resulting in 15 analyses. A conservative 20 
Bonferroni adjustment for multiple testing was used, correcting for 105 tests (given 21 
seven thresholds and 15 analyses), giving a final threshold for significance of p < 22 
0.0004.  23 
 We also performed formal risk score-by-environment analyses to estimate the 24 
effect on MDD of the interaction between genetic variants across the whole genome 25 
14 
(modelled as a polygenic risk score) and reported trauma exposure. These analyses 1 
included the same covariates used in the GWAS, and all risk score-by-covariate and 2 
reported trauma exposure-by-covariate interactions 62,63. Both multiplicative and 3 
additive interactions were tested. A significant multiplicative interaction means that 4 
the combined effect of the risk score and reported trauma exposure differs from the 5 
product of their individual effects. Multiplicative interactions were tested using logistic 6 
regression 25,26. A significant additive interaction means that the combined effect of 7 
the risk score and reported trauma exposure differs from the sum of their individual 8 
effects. Additive interactions were tested using linear regression (Supplementary 9 
Methods). 10 
 11 
Sensitivity analyses  12 
 Differences in phenotypic variables were observed between cases and 13 
controls. To assess the impact of including these variables as covariates, all 14 
analyses were rerun retaining all previous covariates and including as further 15 
covariates: age (at questionnaire), neighbourhood socioeconomic status (SES, as 16 
Townsend deprivation index 37), BMI (at baseline assessment), and a binary variable 17 
of education (university degree vs. not). The same covariates were also included in 18 
polygenic risk score and SNP-based heritability analyses. Sensitivity analyses 19 
focussing on reported trauma exposure as an outcome were similarly rerun 20 
(Supplementary Methods).  21 
 The majority of the sample with data on both MDD symptoms and reported 22 
trauma status were controls who did not report trauma (Table 1). To assess whether 23 
this disbalance in sample status affected our results, genetic correlation analyses 24 
with external phenotypes were rerun on ten downsampled cohorts, each with 9,487 25 
15 
participants (the number of cases not reporting trauma exposure; see 1 
Supplementary Methods). 2 
 In order to test whether our definition of trauma exposure affected the main 3 
finding of our paper, we performed three further sensitivity analyses, redefining 4 
reported trauma exposure. First, we assessed if our main finding was robust to 5 
changing the threshold for including MDD-relevant trauma, by redefining reported 6 
trauma exposure as a report of i) one or more and ii) three or more of the seven 7 
MDD-relevant trauma items. Second, we assessed whether the timing of trauma 8 
exposure affected this finding by redefining reported trauma exposure as a report of 9 
iii) one or more of the five childhood trauma items. We then re-analysed the 10 
heritability of MDD in individuals reporting and not reporting trauma exposure using 11 
these three alternative definitions. 12 
  13 
Code availability 14 




Phenotype distribution 19 
Phenotypic and genetic data were available on 24,094 to 92,957 individuals 20 
(Table 1). Overall, 36% of individuals met our definition of MDD-relevant trauma 21 
exposure, and were more frequently cases (45%) than controls (17%; OR = 5.23; p < 22 
10-50, chi-square test). We assessed a number of phenotypic correlates of 23 
depression to confirm that these correlates differed between MDD cases and 24 
controls, and to assess whether these differences were affected by trauma 25 
16 
exposure. Cases differed significantly from controls overall. Individuals with MDD 1 
were mostly females, significantly younger, less likely to have a university degree, 2 
came from more deprived neighbourhoods, and had higher BMI at recruitment. 3 
These differences persisted when the cohort was limited just to individuals reporting 4 
trauma exposure, and when the cohort was limited just to individuals not reporting 5 
trauma exposure. Furthermore, cases reporting trauma exposure differed from cases 6 
not reporting trauma exposure, in that they were mostly females, younger, more 7 
likely to have a degree (note difference from case-control comparisons), came from 8 
more deprived neighbourhoods, and had higher BMI at recruitment. The same 9 
differences (in the same direction) were observed between controls reporting and not 10 
reporting trauma exposure (all p < 0.05; Supplementary Table 4). 11 
 












 b 9,487 c 6,595 29,475 a 
Controls 10,701
 b 39,677 c 13,104 63,482a 
 
Table 1: Participants available for analysis. 
Groups of individuals used in each of the three analyses are in bold.  
The superscripts denote the groups used in each of the three main analyses:  
a) MDD in all participants (29,475 cases, 63,482 controls, N = 92,957);  
b) MDD in participants reporting trauma exposure (13,393 cases, 10,701 controls, N 
= 24,094);  
c) MDD in participants not reporting trauma exposure (9,487 cases, 39,677 controls, 




Genome-wide association studies 1 
 We performed GWAS for MDD overall and stratified by reported trauma 2 
exposure to obtain results for heritability and genetic correlation analyses 3 
(Supplementary Table 5; Supplementary Figures 1-3). No analysis showed evidence 4 
of genome-wide inflation attributable to confounding (the 95% confidence intervals of 5 
all regression intercepts from LD Score included 1; Supplementary Table 6). One 6 
genome-wide significant locus (rs11515172, Chr 9:11Mb, p = 3.82x10-8) was 7 
identified in the analysis of MDD overall, and remained significant when using logistic 8 
regression (p = 4.69 x 10-8, OR = 0.96, SE = 0.007; Supplementary Table 5). This 9 
locus has been repeatedly associated with depression 15,64,65, and with neuroticism 10 
66–69. However, it should be noted that all of these studies included UK Biobank. The 11 
locus is intergenic, and is not annotated to any currently known biological feature of 12 
interest (Supplementary Table 7). 13 
 14 
SNP-based heritability 15 
 First we estimated the observed scale SNP-based heritability of MDD overall 16 
and stratified by reported trauma exposure. Second, in order to assess whether the 17 
relative influence of genetic variants on MDD differed by reported trauma status, we 18 
converted SNP-heritabilities to the liability scale. We assumed a prevalence of 28% 19 
for self-reported MDD in the full population 2. Based on this, and on the ratio of MDD 20 
cases:controls in the sample, we estimated the prevalence of MDD in the trauma-21 
exposed population as 52%, and in the unexposed population as 17%. Using these 22 
estimates of population prevalence, the liability scale estimate of MDD SNP-based 23 
heritability was 20% (95% confidence interval: [18-22%]) overall. In those reporting 24 
trauma exposure, the liability scale SNP-based heritability of MDD was 24% [18-25 
18 
31%], and in those not reporting trauma exposure it was 12% [7-16%]. The SNP-1 
based heritability of MDD was significantly greater in individuals who reported 2 
trauma exposure compared to those who did not (p = 0.0021, Z-test).  3 
These estimated SNP-heritabilities could be confounded by genetic 4 
correlation between MDD and reported trauma exposure. We designed and 5 
conducted simulations of SNP-level data to quantify the expected difference in SNP-6 
based heritability from genetic correlation alone (Supplementary Methods). Our 7 
simulations yielded expected estimates for the liability scale SNP-based heritability 8 
of MDD of 14-15% in those reporting trauma exposure, and 15-16% in those not 9 
reporting trauma exposure (Supplementary Methods). This small difference in 10 
expected SNP-based heritability for those reporting and not reporting trauma is in the 11 
opposite direction to our findings. This suggests that our findings cannot be 12 
explained by genetic correlation between MDD and reported trauma exposure, nor 13 
by the transformation from the observed scale to the liability scale.  14 
 15 
Genetic correlations 16 
 Genetic correlations were calculated between MDD and reported trauma to 17 
explore the genetic relationship between these traits. Further genetic correlations 18 
were calculated between MDD in the two strata to assess whether genetics 19 
influences on MDD differ in the context of reported trauma exposure (Supplementary 20 
Table 8).  21 
We observed a significant rg between MDD and reported trauma exposure in 22 
the full cohort (0.62 [95% CI: 0.76-0.94], p < 10-50). Given that trauma items were 23 
selected for association with MDD, we also calculated the genetic correlation 24 
between MDD in the full cohort and reported trauma exposure in just the controls, 25 
19 
which was also significant (0.31 [0.18-0.45], p = 4x10-6; Supplementary Table 8). 1 
This correlation persisted when using independent major depression GWAS 2 
summary statistics, as reported trauma exposure was significantly correlated with the 3 
MDD polygenic risk score (Spearman's rho = 0.0675, p < 10-50) 15. The genetic 4 
correlation between MDD in individuals reporting trauma exposure and MDD in 5 
individuals not reporting trauma exposure was high and did not differ significantly 6 
from 1 (rg = 0.77 [0.48-1.05]; difference from 0: p = 1.8 x 10-7; difference from 1: p = 7 
0.11).  8 
Genetic correlations were calculated between MDD and all available external 9 
traits to systematically assess whether genetic relationships with MDD differed in the 10 
context of reported trauma exposure. All psychiatric traits included were significantly 11 
associated (p < 2.5x10-4) with MDD, but this association did not differ substantially in 12 
magnitude between the groups reporting and not reporting trauma exposure (z-test 13 
for comparisons of rg - Δrg - ranged from p = 0.10 - 0.99; Figure 1). In contrast, waist 14 
circumference was significantly associated with MDD only in individuals reporting 15 
trauma exposure (rg = 0.24), and the correlation was significantly larger than that in 16 
individuals not reporting trauma exposure (rg = -0.05, jackknife pΔrg = 2.3x10-4). Other 17 
correlations between MDD and body composition, reproductive, and socioeconomic 18 
phenotypes were larger in the group reporting trauma exposure compared to 19 
individuals not reporting trauma exposure, but these differences did not remain 20 
significant following multiple testing correction (all jackknife p > 2.5x10-4; Figure 1, 21 





Figure 1: Genetic correlations between MDD (overall and stratified by reported 
trauma exposure) and selected traits and disorders. Full genetic correlation results 
are available in Supplementary Table 9. Numbers = genetic correlations. Colour = 
direction of effect (blue = positive, red = negative). Colour intensity = size of 
correlation. Upper and lower bars are 95% confidence interval of genetic correlation. 
 
21 
Polygenic risk scores across strata 1 
 2 
 We performed polygenic risk score analyses to further explore how 3 
stratification by trauma status affects the genetic relationship between MDD and 4 
specific correlates of MDD, and to mirror previous analyses in the literature (Figure 5 
2, Table 2; see Supplementary Table 10 for full details of all risk score analyses, 6 
including the number of SNPs in each score) 26. Individuals with high genetic risk 7 
scores for MDD were more likely to be cases than controls, and a significant additive 8 
interaction term was observed from linear regression. Specifically, the combined 9 
effect of the MDD risk score and reported trauma exposure on MDD was greater 10 
than the sum of the individual effects (beta > 0, Table 2 central panel). However, the 11 
multiplicative interaction term was not significant (p > 0.01). The presence of an 12 
interaction on the additive scale reflects the greater SNP-based heritability of MDD in 13 
individuals reporting trauma exposure (SNP-h2 = 24%) compared to those not 14 
reporting trauma exposure (SNP-h2 = 12%), as described above.  15 
In contrast, although those with higher BMI risk scores were more likely to be 16 
cases than controls, this only passed correction for multiple testing in individuals 17 
reporting trauma exposure. Both the additive (beta > 0) and the multiplicative (OR > 18 
1) interaction terms were significant, suggesting the combined effect on MDD from 19 
BMI risk score and reported trauma exposure together was greater than expected 20 
from both the sum of the individual risks and from their product, respectively (OR > 21 
1). 22 
Individuals with high genetic risk scores for SCZ were more likely to be cases 23 
than controls, but this did not differ between strata (both interaction terms p >0.01). 24 
Individuals with higher BIP risk scores were also more likely to be cases than 25 
controls - although this association was not significant in the subset of individuals 26 
22 
reporting trauma exposure, no significant interaction term was observed, suggesting 1 
the observed difference in results within-strata may be due to differences in power. 2 




Figure 2: Association between MDD polygenic risk score (PRS) and MDD. 
Individuals reporting trauma exposure are shown as orange triangles, and those not 
reporting trauma exposure as green dots. Panel a shows the relationship on the 
linear additive scale, and panel b shows the relationship on the multiplicative scale. 
A significant interaction is observed on the additive scale only, as shown by differing 
slopes of the two regression lines in panel a.  
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PRS x Reported Trauma 
Additive Multiplicative 
OR 95% CI p Beta 95% CI p OR 95% CI p 
MDD  116,404 // 314,990 0.5 
MDD 
  
1.26 1.24-1.28 < 10-50 0.011 0.008-0.014 2.69x10-11 1.01 1.00 - 1.03 0.132 
SCZ 36,989 // 113,075 0.3 1.11 1.09-1.12 1.11 x 10-41 0.008 -0.003-0.004 0.659 0.99 0.97-1.00 0.158 
BIP 7,481 // 9,250 0.2 1.07 1.05-1.08 4.57 x 10-19 -0.000 -0.003-0.003 0.961 0.99 0.97-1.00 0.165 
BMI 339,224 0.3 1.04 1.03-1.06 2.60 x 10-8 0.006 0.003-0.009 1.13x10-4 1.02 1.01-1.04 0.0074 
HB1Ac 46,368 0.001 1.01 1.00-1.02 0.163 0.002 -0.001-0.005 0.186 1.01 0.99-1.02 0.391 




1.24 1.21-1.27 < 10-50  
SCZ 36,989 // 113,075 0.5 1.06 1.03-1.09 2.96 x 10-5 
BIP 7,481 // 9,250 0.5 1.04 1.01-1.07 0.00329 
BMI 339,224 0.5 1.07 1.04-1.10 1.85 x 10-7 
HB1Ac 46,368 0.001 1.02 1.00-1.05 0.0863 
MDD 116,404 // 314,990 0.4 
MDD, no reported 
trauma exposure 
1.21 1.18-1.23 < 10-50  
SCZ 36,989 // 113,075 0.5 1.09 1.06-1.11 4.34 x 10-12 
BIP 7,481 // 9,250 0.2 1.07 1.04-1.09 4.05 x 10-8 
BMI 339,224 0.3 1.02 1.00-1.04 0.0980 
HB1Ac 46,368 0.001 1.01 0.99-1.03 0.492 
Table 2: Main effect and interaction effects for polygenic risk scores (PRS) associated with MDD overall and in stratified analyses. Interaction effects are on 
the additive scale (Beta) and the multiplicative scale (OR). Bold = significant associations (main analyses: p < 0.000143; interactions: p < 0.01). Base N = 
Cases // Controls. OR/Beta = Increase with 1 SD increase in risk score or trauma exposure. Results are reported at the "best" threshold (that with the lowest 
p-value in main effect analyses) - results across all thresholds are reported in Supplementary Table 10. 
0 
 
Sensitivity analyses 1 
 2 
 Four sets of sensitivity analyses were performed. In the first set, all analyses 3 
were repeated using reported trauma exposure as the phenotype, assessed overall 4 
and stratified by MDD (as opposed to the primary analysis, where MDD was the 5 
phenotype and analyses were stratified by reported trauma exposure). Results from 6 
these analyses were broadly similar to the results from the primary analysis 7 
(Supplementary Tables 3-11, Supplementary Figures 4-7).  8 
The second set of sensitivity analyses repeated the primary analyses with 9 
additional covariates to assess the impact of controlling for age, neighbourhood 10 
socioeconomic status, BMI, and education. This did not alter the conclusions drawn 11 
from the GWAS and SNP-based heritability analyses, nor from the genetic 12 
correlations observed between the internal phenotypes (those assessed in this 13 
study; Supplementary Tables 12-17). Genetic correlations between MDD and 14 
external phenotypes did not differ significantly from the main analysis (all z-test p < 15 
0.05), but were sufficiently attenuated that the genetic correlations of MDD with waist 16 
circumference was no longer significantly different between individuals reporting and 17 
not reporting trauma exposure. Differences in the polygenic risk score analyses were 18 
limited to analyses involving the BMI risk score. In analyses adjusted for phenotypic 19 
BMI, the BMI polygenic risk score was no longer associated with MDD in any 20 
analysis, and no interactions including the BMI risk score remained significant.  21 
The third set of sensitivity analyses repeated the genetic correlation analyses, 22 
but downsampled the analysed cohort such that each of the four groups (MDD 23 
cases/controls reporting/not reporting trauma exposure) had 9,487 participants (the 24 
size of the smallest group from the main analysis, cases not reporting trauma 25 
exposure). In these analyses, genetic correlations between MDD and external 26 
1 
phenotypes were attenuated across most phenotypes, but not significantly (two-1 
sample z-tests, all p > 0.05; Supplementary Table 18). As such, the general pattern 2 
of genetic correlations observed in the main analysis was retained, although the 3 
genetic correlations of MDD with waist circumference was no longer significantly 4 
different between individuals reporting and not reporting trauma exposure. 5 
The final set of sensitivity analyses repeated the SNP-based heritability 6 
analyses of MDD in individuals reporting and not reporting trauma exposure, altering 7 
the definition of reported trauma exposure in three ways (increasing and decreasing 8 
the number of items required to be defined as reporting trauma exposure, and 9 
limiting the items considered to only childhood experiences). The purpose of these 10 
analyses was to test the robustness of our key finding (greater MDD SNP-based 11 
heritability in trauma-exposed individuals compared to those not reporting trauma 12 
exposure). Neither increasing nor decreasing the number of MDD-relevant items 13 
selected, nor focussing on childhood items, altered our conclusions (Supplementary 14 
Table 19).  15 
Full results for all four sensitivity analyses, and for variant-level gene-by-16 
environment interaction analyses (Supplementary Table 20), are included in the 17 
Supplementary Material. 18 
 19 
Discussion 20 
We investigated the relationship between MDD and self-reported trauma 21 
exposure in the largest single cohort available to date (N=73,258 with MDD and 22 
reported trauma data). The SNP-based heritability of MDD was higher in individuals 23 
reporting trauma exposure than in individuals not reporting trauma exposure. This 24 
was not explained by gene-environment correlation, or the transformation of SNP-25 
2 
based heritability from the observed to the liability scale. Despite the significant 1 
difference in SNP-based heritability across the two strata, the genetic correlation 2 
between MDD in individuals reporting and not reporting trauma exposure was not 3 
statistically different from 1. Polygenic risk score-by-reported trauma exposure 4 
interaction analyses identified significant interactions for both MDD and BMI risk 5 
scores. However, the interactions involving the BMI risk score appear to be 6 
explained by differences in measured BMI between MDD cases and controls. Finally, 7 
a significant genetic correlation between MDD and waist circumference was 8 
observed only in individuals reporting trauma exposure, and was absent from those 9 
not reporting trauma exposure. 10 
 11 
A number of limitations should be considered when assessing our results. Our 12 
simulations suggest that our SNP-based heritability differences did not result from 13 
gene-environment correlation between MDD and reported trauma exposure, nor the 14 
conversion of observed scale SNP-based heritabilities to the liability scale. However, 15 
we could not address further sources of potential bias. These could arise from non-16 
additive genetic architectures, ascertainment bias and the effects of covariates not 17 
included in the model 70,71, or from potential collider bias resulting from selection bias 18 
72. We also assumed that the population prevalence of reported trauma exposure 19 
can be extrapolated from that observed in this sample (see Supplementary 20 
Methods). Although the UK Biobank allows us to integrate genetic and environmental 21 
data at scale, and is a reasonably homogeneous cohort, it also has a "healthy 22 
volunteer bias", whereby the participants tend to have better overall health and 23 
higher socioeconomic status compared to the equivalent overall population of this 24 
age 73. It is possible that the depressive and traumatic experiences reported by these 25 
3 
participants may not generalise to the whole population, or to clinically-ascertained 1 
cases. Furthermore, we focussed on European ancestry; further studies in non-2 
European populations are required 74. 3 
To obtain further insight into the association of genome-wide genetic variation 4 
and reported trauma exposure with MDD (and to enable comparison with previous 5 
studies 24–26), we carried out polygenic risk score-by-environment interaction 6 
analyses. There are a number of limitations to consider when interpreting such 7 
analyses. Polygenic risk score-by-environment interaction analyses test a specific 8 
hypothesis, namely that the overall association of common variants with the outcome 9 
(modelled as a risk score) varies dependent on the environmental exposure being 10 
tested. We did not test the existence of specific variant-by-environment interactions, 11 
including those featuring variants contributing to the risk score. Furthermore, we 12 
cannot exclude the possibility that the correlation between the MDD and BMI risk 13 
scores with reported trauma exposure may alter the observed interactions. This 14 
prevents the drawing of strong conclusions, especially given the limited predictive 15 
power of the risk scores used in this study (Supplementary Table 10). 16 
Throughout this paper, we have referred to our depression phenotype as 17 
"MDD" rather than "major depression". We do this because our definition is based on 18 
the CIDI-SF, which has previously been shown to have good concordance with direct 19 
clinical assessments of MDD 75,76. However, it should be noted that direct 20 
assessment was not performed, and our MDD cases may not have met criteria 21 
within a clinical setting. Nonetheless, genetic correlations between studies of clinical 22 
MDD and our definition are very high, suggesting there is strong genetic continuity 23 
across different methods of assessing depression 15,65.  24 
4 
Trauma exposure was defined in this study using retrospective self-report. 1 
This is not the ideal measure for this phenotype, and precludes robust measurement 2 
of the severity and timing of the reported trauma exposure. However, retrospective 3 
report is the only feasible option for cohorts large enough to enable detailed genetic 4 
analyses of the interaction between trauma and MDD. Retrospectively reported 5 
trauma and MDD are also not robust to reverse causation, and our results cannot 6 
strongly inform any temporal or causal hypotheses about their relationship. Such 7 
hypotheses could be tested using (extensive) longitudinal studies or through more 8 
powerful genomic studies of trauma exposure including data from similar or larger 9 
cohorts. This could enable the identification of sufficient robustly associated genetic 10 
variants to inform approaches such as Mendelian randomisation (which we were 11 
underpowered to examine in this study). In addition, future work may benefit from 12 
assessing the heritability of broader depression phenotypes that lie beyond our 13 
binary criteria, including reward sensitivity and negative valence traits 77. 14 
 15 
Our findings suggest that the genetic variants associated with MDD are the 16 
same in individuals reporting and not reporting trauma exposure, because the 17 
genetic correlation between MDD measured in these two groups was not 18 
significantly different from 1. However, the SNP-based heritability of MDD was 19 
greater in individuals reporting compared to not reporting trauma exposure. This 20 
suggests that the combined effect of the variants associated with MDD is greater in 21 
people reporting trauma exposure than in those who do not. The mechanism 22 
underlying this finding is uncertain. One possibility is that exposure to traumatic 23 
events might amplify genetic influences on MDD beyond the magnitude of the effects 24 
seen in the absence of trauma (consistent with the stress-diathesis hypothesis 78–80). 25 
5 
The concept that genetic variance varies with exposure to different environments is 1 
well-recognised in studies of animal populations in the wild 81. However, the opposite 2 
may also be true; genetic influences on MDD could increase an individual's likelihood 3 
of experiencing and/or reporting of trauma, and through doing so increase the 4 
apparent heritability of MDD by partly incorporating genetic influences related to 5 
trauma reporting itself 11. A third possibility relates to the components of variance 6 
involved in calculating SNP-based heritability. Phenotypic variance can be attributed 7 
either to the SNPs measured in the GWAS, or to environmental sources of variance 8 
reflecting all phenotypic variance not explained by common variants. It is possible 9 
that the genetic variance is constant across the strata, but that the environmental 10 
variance is decreased when only considering individuals reporting trauma exposure, 11 
due to the shared (and thus more similar/less variable) exposure of these individuals 12 
to MDD-relevant traumatic experiences. This would result in greater heritability in 13 
individuals reporting trauma exposure. These explanations are potential 14 
interpretations of these findings but are not the only possibilities. It is also likely that 15 
multiple such mechanisms are involved. 16 
A final, separate, possibility is that self-report is impaired in the group 17 
reporting trauma exposure. Reported trauma exposure is associated with an 18 
increased prevalence of multiple psychiatric disorders including personality 19 
disorders. The rapidly fluctuating symptoms of personality disorders can reduce the 20 
reliability of self-report in affected individuals 82. If self-report is less reliable in those 21 
reporting trauma exposure, this would affect the accuracy of our MDD definition in 22 
this group, such that the cases in this group may also include unreported cases of 23 
excluded disorders with higher heritability, such as bipolar disorder or schizophrenia. 24 
Although the reported prevalence of personality disorder diagnosis in this cohort is 25 
6 
too low to explain the observed differences in SNP-based heritability (142/22,880 1 
MDD cases, <1% of MDD cases), the participants in the study have not undergone 2 
more extensive assessment, and further diagnoses of personality disorders may 3 
have been missed. 4 
 5 
In polygenic risk score-by-reported trauma exposure interaction analyses, we 6 
identified a significant interaction on the additive scale for the combined effect of the 7 
MDD risk score and reported trauma exposure on risk of MDD. These results are 8 
also reflected in the larger SNP-based heritability of MDD in exposed compared to 9 
unexposed individuals. The simplest explanation for this result is that the effects of 10 
the MDD risk score and reported trauma exposure on MDD combine multiplicatively, 11 
such that their combined effects are greater than the sum of their individual effects. 12 
For the BMI risk score however, the interaction with reported trauma exposure 13 
appears to be more complex, combining neither additively nor multiplicatively. In 14 
sensitivity analyses controlling for BMI (obtained at recruitment, approximately five 15 
years before the mental health questionnaire), the BMI risk score-by-reported trauma 16 
exposure interaction was no longer significant, suggesting that the observed 17 
interaction can be explained by differences in measured BMI. Further research, with 18 
concurrent measurements of BMI, trauma exposure and MDD in a longitudinally-19 
sampled cohort would offer further insight into the relationship between these three 20 
variables. 21 
The high genetic correlation between MDD in individuals reporting and not 22 
reporting trauma exposure was supported by significant genetic correlations between 23 
MDD and other psychiatric disorders regardless of reported trauma exposure. In 24 
individuals reporting trauma exposure, a further significant genetic correlation was 25 
7 
observed between MDD and waist circumference, which was significantly greater 1 
than the equivalent correlation in those not reporting trauma exposure. Although not 2 
significant, there was also a general pattern of higher genetic correlations between 3 
MDD and several weight-related measures and educational attainment, in individuals 4 
reporting trauma exposure. This is consistent with previous literature on traumatic 5 
experiences and related phenomena such as Adverse Childhood Experiences, which 6 
has found that they are associated not only with psychiatric risk but also with wide-7 
ranging impairments in social and health outcomes including obesity and (less) 8 
education 83–86. However, we stress that causal conclusions cannot be drawn from 9 
these (or our) data, or that the reported trauma exposure is responsible for the 10 
observed differences. 11 
Our estimate of the SNP-based heritability of MDD (20%) is higher than that 12 
reported in previous studies of major depression (~9%) 15. This may be explained by 13 
the relative homogeneity of the UK Biobank compared to previous meta-analyses. 14 
The UK Biobank is a single-country cohort ascertained using a consistent protocol. 15 
The same questionnaire was used to gather symptom data, and the samples were 16 
stored, extracted, and genotyped using a single method. In contrast, meta-analyses 17 
have needed to combine diverse ascertainment, sampling, and genotyping; SNP-18 
based heritability has been reported to decrease with increasing numbers of meta-19 
analysed samples 87. Previous analyses have assessed alternative depression 20 
phenotypes in the UK Biobank 65.  21 
Our MDD phenotype (based on DSM criteria for MDD) is most similar to the 22 
probable MDD phenotype from Howard et al, rather than the less strictly-defined 23 
"broad depression" phenotype, which includes those who seek treatment for 24 
depression, anxiety and related phenotypes. Our summary statistics LDSC-based 25 
8 
estimate is higher than the equivalent from Howard et al (4-5%). However, our 1 
estimate using genotype data (20%) is within the bounds of equivalent estimates by 2 
geographic region reported for the probable MDD (0% to 27.5%) phenotype. We 3 
note that our MDD phenotype definition may have more specificity than the probable 4 
MDD phenotype used in Howard et al.  5 
Our results also differ in several respects from those of a study of MDD and 6 
adversity in Han Chinese women 23. No difference in the SNP-based heritability of 7 
MDD between individuals reporting and not reporting trauma exposure was observed 8 
in the previous study, and we did not replicate individual variant results. However, 9 
this is unsurprising, as there are a number of differences between the studies of 10 
which the primary one is sample size (this study: 73,258; CONVERGE: 9,599). Other 11 
differences included culture and ethnicity, and the deeper phenotyping methodology 12 
applied in CONVERGE, resulting in a severe inpatient MDD phenotype. Notably, the 13 
previous study did not report a genetic correlation between MDD and trauma 14 
exposure 23. 15 
Sensitivity analyses focussed on trauma found that self-reported traumatic 16 
experience was significantly heritable, as has been previously observed 19. We 17 
strongly emphasise that this does not necessarily imply that traumatic experiences 18 
themselves have a biological component - such experiences may be associated with 19 
other significantly heritable traits, and their biology would then be reflected in the 20 
observed heritability of trauma exposure. One potential set of heritable traits that 21 
may be associated with reporting traumatic experiences are personality traits such 22 
as risk-taking, and this might explain the observed genetic correlations with 23 
psychiatric traits. A similar phenomenon has been proposed to underlie observed 24 
genetic correlations with socioeconomic status 88. Our trauma exposure measure 25 
9 
relies on retrospective self-report, which is itself correlated with personality traits and 1 
mood at time of report 9. This may also explain the genetic correlations we observe 2 
with reported trauma exposure (including in controls, who do not report previous 3 
psychiatric illness).  4 
 5 
In summary, we find that genetic associations with MDD in UK Biobank vary 6 
by context. Specifically, the SNP-based heritability of MDD is larger in individuals 7 
reporting trauma exposure compared to those not doing so. Furthermore, the genetic 8 
correlation of MDD with waist circumference was significant only in individuals 9 
reporting exposure to trauma. Nonetheless, a strong genetic correlation was 10 
observed between MDD measured in the two strata. Together, these findings 11 
suggest the relative contribution of genetic variants to variance in MDD is greater 12 
when additional risk factors are present.  13 
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